Evofem Biosciences Inc (EVFM)
0.012
0.00 (0.00%)
USD |
OTCM |
May 03, 15:59
Evofem Biosciences Total Assets (Quarterly): 10.55M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.55M |
| September 30, 2023 | 13.32M |
| June 30, 2023 | 14.07M |
| March 31, 2023 | 26.03M |
| December 31, 2022 | 25.16M |
| September 30, 2022 | 42.28M |
| June 30, 2022 | 53.47M |
| March 31, 2022 | 34.57M |
| December 31, 2021 | 42.51M |
| September 30, 2021 | 67.43M |
| June 30, 2021 | 108.75M |
| March 31, 2021 | 93.46M |
| December 31, 2020 | 109.97M |
| September 30, 2020 | 112.33M |
| June 30, 2020 | 135.06M |
| March 31, 2020 | 15.64M |
| December 31, 2019 | 28.30M |
| September 30, 2019 | 38.99M |
| June 30, 2019 | 54.42M |
| March 31, 2019 | 3.234M |
| Date | Value |
|---|---|
| December 31, 2018 | 4.01M |
| September 30, 2018 | 15.03M |
| June 30, 2018 | 26.17M |
| March 31, 2018 | 8.992M |
| December 31, 2017 | 3.952M |
| September 30, 2017 | 6.246M |
| June 30, 2017 | 8.214M |
| March 31, 2017 | 10.73M |
| December 31, 2016 | 12.82M |
| September 30, 2016 | 15.21M |
| June 30, 2016 | 22.58M |
| March 31, 2016 | 25.53M |
| December 31, 2015 | 40.11M |
| September 30, 2015 | 52.67M |
| June 30, 2015 | 64.19M |
| March 31, 2015 | 71.92M |
| December 31, 2014 | 76.90M |
| September 30, 2014 | 16.19M |
| December 31, 2013 | 4.530M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.55M
Minimum
Dec 2023
135.06M
Maximum
Jun 2020
54.02M
Average
42.28M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 77.06M |
| Shareholders Equity (Quarterly) | -66.51M |
| Debt to Equity Ratio | -0.6505 |
| Current Ratio | 0.1271 |
| Net Debt Paydown Yield | 535.1% |